BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31626863)

  • 1. Trends in prevalence of healthcare-associated infections and antimicrobial use in hospitals in the Netherlands: 10 years of national point-prevalence surveys.
    Hopmans TEM; Smid EA; Wille JC; van der Kooi TII; Koek MBG; Vos MC; Geerlings SE; de Greeff SC
    J Hosp Infect; 2020 Feb; 104(2):181-187. PubMed ID: 31626863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A point-prevalence survey of healthcare-associated infection in fifty-two Chinese hospitals.
    Chen Y; Zhao JY; Shan X; Han XL; Tian SG; Chen FY; Su XT; Sun YS; Huang LY; Han L;
    J Hosp Infect; 2017 Jan; 95(1):105-111. PubMed ID: 28007308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The first multi-centre point-prevalence survey in four Japanese university hospitals.
    Morioka H; Nagao M; Yoshihara S; Ohge H; Kasahara K; Shigemoto N; Kajihara T; Mori M; Iguchi M; Tomita Y; Ichiyama S; Yagi T
    J Hosp Infect; 2018 Jul; 99(3):325-331. PubMed ID: 29549049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional point prevalence study of healthcare-associated infections and antimicrobial use in acute care hospitals in Liguria, Italy.
    Sticchi C; Alberti M; Artioli S; Assensi M; Baldelli I; Battistini A; Boni S; Cassola G; Castagnola E; Cattaneo M; Cenderello N; Cristina ML; De Mite AM; Fabbri P; Federa F; Giacobbe DR; La Masa D; Lorusso C; Marioni K; Masi VM; Mentore B; Montoro S; Orsi A; Raiteri D; Riente R; Samengo I; Viscoli C; Carloni R;
    J Hosp Infect; 2018 May; 99(1):8-16. PubMed ID: 29253622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring healthcare-associated infections and antimicrobial use at regional level through repeated point prevalence surveys: what can be learnt?
    Arnoldo L; Smaniotto C; Celotto D; Brunelli L; Cocconi R; Tignonsini D; Faruzzo A; Brusaferro S;
    J Hosp Infect; 2019 Apr; 101(4):447-454. PubMed ID: 30597175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results from the third Scottish National Prevalence Survey: is a population health approach now needed to prevent healthcare-associated infections?
    Cairns S; Gibbons C; Milne A; King H; Llano M; MacDonald L; Malcolm W; Robertson C; Sneddon J; Weir J; Reilly J
    J Hosp Infect; 2018 Jul; 99(3):312-317. PubMed ID: 29621601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determining the effect of social deprivation on the prevalence of healthcare-associated infections in acute hospitals: a multivariate analysis of a linked data set.
    Packer SJ; Cairns S; Robertson C; Reilly JS; Willocks LJ
    J Hosp Infect; 2015 Dec; 91(4):351-7. PubMed ID: 26446849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 2017 global point prevalence survey of antimicrobial consumption and resistance in Canadian hospitals.
    Frenette C; Sperlea D; German GJ; Afra K; Boswell J; Chang S; Goossens H; Grant J; Lefebvre MA; McGeer A; Mertz D; Science M; Versporten A; Thirion DJG
    Antimicrob Resist Infect Control; 2020 Jul; 9(1):104. PubMed ID: 32653046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of nosocomial infections in The Netherlands, 2007-2008: results of the first four national studies.
    van der Kooi TI; Manniën J; Wille JC; van Benthem BH
    J Hosp Infect; 2010 Jul; 75(3):168-72. PubMed ID: 20381910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The first point prevalence survey of health care-associated infection and antimicrobial use in a Japanese university hospital: A pilot study.
    Morioka H; Hirabayashi A; Iguchi M; Tomita Y; Kato D; Sato N; Hyodo M; Kawamura N; Sadomoto T; Ichikawa K; Inagaki T; Kato Y; Kouyama Y; Ito Y; Yagi T
    Am J Infect Control; 2016 Jul; 44(7):e119-23. PubMed ID: 27372390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Burden of healthcare-associated infections in China: results of the 2015 point prevalence survey in Dong Guan City.
    Wang J; Hu J; Harbarth S; Pittet D; Zhou M; Zingg W
    J Hosp Infect; 2017 Jun; 96(2):132-138. PubMed ID: 28325579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Point prevalence survey of antimicrobial use and healthcare-associated infections in Belgian acute care hospitals: results of the Global-PPS and ECDC-PPS 2017.
    Vandael E; Latour K; Goossens H; Magerman K; Drapier N; Catry B; Versporten A;
    Antimicrob Resist Infect Control; 2020; 9(1):13. PubMed ID: 31956402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial use in acute care hospitals: national point prevalence survey on healthcare-associated infections and antimicrobial use, Switzerland, 2017.
    Zingg W; Metsini A; Gardiol C; Balmelli C; Behnke M; Troillet N; Widmer A; Pittet D;
    Euro Surveill; 2019 Aug; 24(33):. PubMed ID: 31431211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of case vignettes for assessment of the inter-rater variability of national validation teams for the point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals.
    van Hauwermeiren E; Iosifidis E; Kärki T; Suetens C; Kinross P; Plachouras D
    J Hosp Infect; 2019 Apr; 101(4):455-460. PubMed ID: 30682398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Healthcare-associated infections and antimicrobial use in acute care hospitals: a point prevalence survey in Lombardy, Italy, in 2022.
    Antonelli A; Ales ME; Chiecca G; Dalla Valle Z; De Ponti E; Cereda D; Crottogini L; Renzi C; Signorelli C; Moro M
    BMC Infect Dis; 2024 Jun; 24(1):632. PubMed ID: 38918691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of healthcare-associated infections in Lithuania.
    Valinteliene R; Gailiene G; Berzanskyte A
    J Hosp Infect; 2012 Jan; 80(1):25-30. PubMed ID: 22071001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. THE GLOBAL POINT PREVALENCE SURVEY (PPS) OF ANTIMICROBIAL USE AND ANTIMICROBIAL RESISTANCE AMONG HOSPITALIZED CHILDREN IN GEORGIA.
    Korinteli IG; Mchedlishvili I; Javakhadze M; Versporten A; Goossens H; Phagava H; Pagava K
    Georgian Med News; 2019; (292-293):72-75. PubMed ID: 31560667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated nationwide point-prevalence surveys of antimicrobial use in Swedish hospitals: data for actions 2003-2010.
    Skoog G; Struwe J; Cars O; Hanberger H; Odenholt I; Prag M; Skärlund K; Ulleryd P; Erntell M
    Euro Surveill; 2016 Jun; 21(25):. PubMed ID: 27367646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use.
    Zarb P; Coignard B; Griskeviciene J; Muller A; Vankerckhoven V; Weist K; Goossens M; Vaerenberg S; Hopkins S; Catry B; Monnet D; Goossens H; Suetens C; ;
    Euro Surveill; 2012 Nov; 17(46):. PubMed ID: 23171822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 2018 Global Point Prevalence Survey of antimicrobial consumption and resistance in 47 Canadian hospitals: a cross-sectional survey.
    German GJ; Frenette C; Caissy JA; Grant J; Lefebvre MA; Mertz D; Lutes S; McGeer A; Roberts J; Afra K; Valiquette L; Émond Y; Carrier M; Lauzon-Laurin A; Nguyen TT; Al-Bachari H; Kosar J; Peermohamed S; Science M; Landry D; MacLaggan T; Daley P; McDonald G; Ang A; Chang S; Lin YC; Tong B; Malfair S; Leung V; Katz K; Pauwels I; Goossens H; Versporten A; Conly J; Thirion DJG
    CMAJ Open; 2021; 9(4):E1242-E1251. PubMed ID: 34933882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.